PharmAccess mobilizes public and private resources for the benefit of doctors and patients through clinical standards and quality improvements, loans for healthcare providers, health insurance, mHealth innovations and operational research.
PharmAccess mobilizes public and private resources for the benefit of doctors and patients through clinical standards and quality improvements, loans for healthcare providers, health insurance, mHealth innovations and operational research.
.
Medical Credit Fund has been granted ANBI status by the Dutch Tax and Customs Administration. The Dutch abbreviation ANBI means Algemeen Nut Beogende Instelling, or Public Benefit Organization. Institutions can only be qualified as a public benefit organization if at least 90% of their efforts are focused on the common good.
In light of revised regulations, organizations with the ANBI status are required by law to publish the information mentioned below on their websites as per 1st of January 2014.
Name of the institution
Stichting Medical Credit Fund, a not-for-profit foundation established in Amsterdam, hereinafter referred to as Medical Credit Fund.
RSIN/fiscal number
Medical Credit Fund’s RSIN number is 821004517. The Chamber of Commerce number is 34348645.
Contact details
Medical Credit Fund
AHTC, Tower 4C, Paasheuvelweg 25, 1105 BP Amsterdam, The Netherlands
P.O. Box 22700, 1100 DE Amsterdam, The Netherlands
Tel. +31 (0)20 210 3920/ contact@medicalcreditfund.org
Objectives
Medical Credit Fund supports private healthcare facilities in Africa obtaining capital to strengthen and upgrade their operations in order to enhance access to affordable quality healthcare.
Medical Credit Fund’s vision is to enhance the provision of affordable quality healthcare services in Sub Saharan Africa to low-income Africans. The mission is to enable primary health care providers in Africa to access investment capital so they can improve the quality of their services and expand their facility.
The objectives are to provide access to loans from local banks for around 2500 healthcare facilities, complemented with a comprehensive technical assistance program on quality improvement and business planning leading to external evaluation (SafeCare) of the facility’s performance.
Policy plan
A concise version of our policy plan will be available here shortly.
Governance
The Statutory Board of Stichting Medical Credit Fund consists of the Executive Board of Stichting PharmAccess Group Foundation and Arjan Poels.
The members of the Statutory Board are:
The Statutory Board of Stichting Medical Credit Fund is supervised by the Supervisory Board of Stichting PharmAccess Group Foundation.
The members of the Supervisory Board of Stichting PharmAccess Group Foundation are:
Board members can be contacted via contact@medicalcreditfund.org.
Remuneration policy
The “DG-norm” (also called “MFS II norm”) was introduced by the Dutch Ministry of Foreign Affairs at the end of 2009. According to this salary standard, the directors of organizations involved in development cooperation do not earn more than the basic salary earned by a Director-General (DG) at a Dutch Ministry. Medical Credit Fund adheres to this norm, and is also compliant with the “VFI-norm” and the “Wet Normering Topinkomens”, formerly known as the “Balkenende-norm.”
Supervisory Board members are unpaid. They receive no remuneration or expense allowance. They do have the right to request compensation for costs incurred, such as travel expenses or telephone costs.
Report on recent activities
Please consult the PharmAccess Progress Report 2023 the PharmAccess Annual Accounts 2023 and the MCF I Annual Report 2023, MCF II Annual Report 2023
Financial accountability
Medical Credit Fund’s financial resources may consist of subsidies, donations, bequests, assets acquired by testamentary disposition and any further revenues. The implementation of accounting and preparation of financial statements has been outsourced to Deloitte. The financial statements and explanatory notes are approved each year by the Supervisory Board. Click here to read the financial statements and explanatory notes pertaining to the year 2023.
Publication requirement ANBI
Find the ‘Standaardformulier ANBI Algemeen’ (2024) here
